Liquid blood tests for early esophageal cancer
Treatments studied
Part of Cancer, Digestive system clinical trials.
This trial studies how well “liquid biopsy” blood tests can work in people with newly diagnosed, operable esophageal cancer. It may help doctors monitor the cancer and guide treatment planning alongside standard care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’re 18 or older
- You have a new diagnosis of esophageal cancer confirmed by pathology
- Your cancer is found only in the chest/region (not spread to distant sites)
- Your cancer type is squamous cell cancer or adenocarcinoma
- Your treatment plan involves a multidisciplinary team decision and surgery is planned after that team meeting
- You can sign consent to join the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a combination of chemotherapy, immunotherapy, and radiation for esophageal cancer that cannot be surgically removed. It also uses a simple blood test (ctDNA) to monitor your cancer's response throughout treatment.
This trial uses a blood test to track genetic changes in esophageal cancer over time. It aims to see if these changes can show how well treatment is working.
This trial tests a new blood test that may find early signs of cancer in people who have no symptoms. If you join, you'll have a blood draw, and the study will check if the test can catch cancer early.
This trial tests whether a personalized treatment plan, chosen using a lab-grown model of your tumor, works better than standard therapy for esophageal cancer that can be surgically removed. It aims to find the most effective drugs for you before surgery.
This trial uses a blood test to find tiny bits of tumor DNA after surgery. If the test is positive, you may receive additional therapy to lower the risk of cancer coming back.
This study collects blood and biopsy tissue from people who are having an upper endoscopy at UNC for Barrett’s esophagus or esophageal cancer. The samples help researchers build a biorepository to study these conditions and support future research.
Hear when a new Esophageal Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.